How China turned the table on biopharma’s global dealmaking

Fenlai Tan still gets chills thinking about the darkest day of his life.

Fenlai Tan

Three out of eight lung cancer patients who received a tyrosine kinase inhibitor developed by his company, Betta Pharma, died in the span of a month. Tan, the chief medical officer,...

Click to view original post